Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.

Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01964-18. doi: 10.1128/AAC.01964-18. [Epub ahead of print]

2.

Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study.

Shivakoti R, Gupte N, Tripathy S, Poongulali S, Kanyama C, Berendes S, Cardoso SW, Santos BR, La Rosa A, Mwelase N, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Bollinger RC, Balagopal A, Semba RD, Christian P, Campbell TB, Gupta A; NWCS 319 and PEARLS Study Team.

BMC Med. 2018 Sep 24;16(1):161. doi: 10.1186/s12916-018-1150-3.

3.

Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.

Belgaumkar V, Chandanwale A, Valvi C, Pardeshi G, Lokhande R, Kadam D, Joshi S, Gupte N, Jain D, Dhumal G, Deluca A, Golub J, Gupta A, Kinikar A, Bollinger RC.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1179-1187. doi: 10.5588/ijtld.17.0848.

PMID:
30236186
4.

The association of household fine particulate matter and kerosene with tuberculosis in women and children in Pune, India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Paradkar M, Kulkarni V, Pradhan N, Breysse PN, Gupta A, Golub JE.

Occup Environ Med. 2019 Jan;76(1):40-47. doi: 10.1136/oemed-2018-105122. Epub 2018 Sep 7.

PMID:
30194271
5.

Challenges and opportunities for outreach workers in the Prevention of Mother to Child Transmission of HIV (PMTCT) program in India.

Suryavanshi N, Mave V, Kadam A, Kanade S, Sivalenka S, Kumar VS, Harvey P, Gupta R, Hegde A, Gupte N, Gupta A, Bollinger RC, Shankar A.

PLoS One. 2018 Sep 4;13(9):e0203425. doi: 10.1371/journal.pone.0203425. eCollection 2018.

6.

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01383-18. doi: 10.1128/AAC.01383-18. Print 2018 Nov.

PMID:
30126955
7.

Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.

Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team.

PLoS One. 2018 Aug 1;13(8):e0199360. doi: 10.1371/journal.pone.0199360. eCollection 2018.

8.

Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):800-806. doi: 10.5588/ijtld.18.0026.

9.

Prevalence and Correlates of Snuff Use, and its Association With Tuberculosis, Among Women Living With HIV in South Africa.

Elf JL, Variava E, Chon S, Lebina L, Motlhaoleng K, Gupte N, Niaura R, Abrams D, Martinson N, Golub JE.

Nicotine Tob Res. 2018 Jul 6. doi: 10.1093/ntr/nty137. [Epub ahead of print]

PMID:
29986070
10.

Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.

Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A; NWCS 319 and ACTG PEARLS Study Team.

Clin Nutr. 2018 May 29. pii: S0261-5614(18)30199-7. doi: 10.1016/j.clnu.2018.05.014. [Epub ahead of print]

PMID:
29885777
11.

Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?

Shivakumar SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Sivaramakrishnan GN, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N, Swaminathan S, Mave V, Gupta A.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):686-694. doi: 10.5588/ijtld.17.0598.

PMID:
29862955
12.

Sources of household air pollution and their association with fine particulate matter in low-income urban homes in India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Breysse PN, Gupta A, Golub JE.

J Expo Sci Environ Epidemiol. 2018 Jun;28(4):400-410. doi: 10.1038/s41370-018-0024-2. Epub 2018 May 23.

13.

Intestinal Barrier Dysfunction and Microbial Translocation in Human Immunodeficiency Virus-Infected Pregnant Women Are Associated With Preterm Birth.

Shivakoti R, Gupte N, Kumar NP, Kulkarni V, Balasubramanian U, Bhosale R, Sambrey P, Kinikar A, Bharadwaj R, Patil S, Inamdar S, Suryavanshi N, Babu S, Bollinger RC, Gupta A.

Clin Infect Dis. 2018 Sep 14;67(7):1103-1109. doi: 10.1093/cid/ciy253.

PMID:
29590318
14.

Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.

Nimkar S, Valvi C, Kadam D, Rewari BB, Kinikar A, Gupte N, Suryavanshi N, Deluca A, Shankar A, Golub J, Bollinger R, Gupta A, Marbaniang I, Mave V.

HIV Med. 2018 Jul;19(6):395-402. doi: 10.1111/hiv.12605. Epub 2018 Mar 24.

PMID:
29573312
15.

Mobile Phone Incentives for Childhood Immunizations in Rural India.

Seth R, Akinboyo I, Chhabra A, Qaiyum Y, Shet A, Gupte N, Jain AK, Jain SK.

Pediatrics. 2018 Apr;141(4). pii: e20173455. doi: 10.1542/peds.2017-3455. Epub 2018 Mar 14.

PMID:
29540571
16.

Cardiovascular risk in an HIV-infected population in India.

Marbaniang IP, Kadam D, Suman R, Gupte N, Salvi S, Patil S, Shere D, Deshpande P, Kulkarni V, Deluca A, Gupta A, Mave V.

Heart Asia. 2017 Jun 30;9(2):e010893. doi: 10.1136/heartasia-2017-010893. eCollection 2017.

17.

TB Risk Perceptions among Medical Residents at a Tertiary Care Center in India.

Pardeshi GS, Kadam D, Chandanwale A, Deluca A, Khobragade P, Parande M, Suryavanshi N, Kinikar A, Basavaraj A, Girish S, Shelke S, Gupte N, Farley J, Bollinger R.

Tuberc Res Treat. 2017;2017:7514817. doi: 10.1155/2017/7514817. Epub 2017 Nov 22.

18.

Transport, diffusion, and energy studies in the Arnold-Beltrami-Childress map.

Das S, Gupte N.

Phys Rev E. 2017 Sep;96(3-1):032210. doi: 10.1103/PhysRevE.96.032210. Epub 2017 Sep 11.

PMID:
29346902
19.

Gender-based violence screening methods preferred by women visiting a public hospital in Pune, India.

Suryavanshi N, Naik S, Waghmare S, Gupte N, Khan S, Mave V, Deluca A, Gupta A, Golub J, Bollinger RC, Shankar A.

BMC Womens Health. 2018 Jan 15;18(1):19. doi: 10.1186/s12905-018-0515-2.

20.

Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.

Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte A, Gupta A, Gupte N, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1280-1287. doi: 10.5588/ijtld.17.0474.

21.

The significance of cytomegalovirus in children with pneumonia admitted for mechanical ventilation.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):800-806. doi: 10.5588/ijtld.17.0026.

PMID:
29297442
22.

Secondhand Smoke Exposure and Validity of Self-Report in Low-Income Women and Children in India.

Elf JL, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar S, Raichur P, Cohen J, Breysse PN, Gupta A, Golub JE.

Pediatrics. 2018 Jan;141(Suppl 1):S118-S129. doi: 10.1542/peds.2017-1026O.

23.

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.

Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M.

PLoS One. 2017 Dec 7;12(12):e0189101. doi: 10.1371/journal.pone.0189101. eCollection 2017.

24.

Prevalence and Correlates of Smoking Among People Living With HIV in South Africa.

Elf JL, Variava E, Chon S, Lebina L, Motlhaoleng K, Gupte N, Niaura R, Abrams D, Golub JE, Martinson N.

Nicotine Tob Res. 2018 Aug 14;20(9):1124-1131. doi: 10.1093/ntr/ntx145.

PMID:
29065199
25.

Household food insecurity is associated with low interferon-gamma levels in pregnant Indian women.

Vaidya A, Bhosale R, Sambarey P, Suryavanshi N, Young S, Mave V, Kanade S, Kulkarni V, Deshpande P, Balasubramanian U, Elf J, Gupte N, Gupta A, Mathad JS.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):797-803. doi: 10.5588/ijtld.16.0718.

PMID:
28633705
26.

Tuberculosis screening among persons with diabetes mellitus in Pune, India.

Mave V, Nimkar S, Prasad H, Kadam D, Meshram S, Lokhande R, Gupte N, Jain D, Gupta A, Golub JE.

BMC Infect Dis. 2017 Jun 2;17(1):388. doi: 10.1186/s12879-017-2483-9.

27.

Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission.

Kinikar A, Gupte N, Bhat J, Bharadwaj R, Kulkarni V, Bhosale R, McIntire KN, Mave V, Suryavanshi N, Patil S, Bollinger R, Gupta A.

Sex Transm Dis. 2017 Jun;44(6):371-375. doi: 10.1097/OLQ.0000000000000622.

28.

High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.

Kadam D, Chandanwale A, Bharadwaj R, Nevrekar N, Joshi S, Patil S, Gupte N, Sangle S, Chopade K, Kulkarni V, Balasubramanian U, Suryavanshi N, Jain D, Kanade S, Dharmashale S, Kagal A, Gupta A, Mave V.

Indian J Med Microbiol. 2017 Jan-Mar;35(1):105-108. doi: 10.4103/ijmm.IJMM_15_596.

29.

Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.

Shaikh N, Gupte A, Dharmshale S, Pokkali S, Thakar M, Upadhye VJ, Ordonez AA, Kinikar A, Gupte N, Mave V, Kagal A, Gupta A, Lalvani A, Paranjpe R, Bharadwaj R, Jain SK.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):412-419. doi: 10.5588/ijtld.16.0428.

30.

Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study.

Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A; NWCS319 and ACTG 5175 study team.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):e71-e79. doi: 10.1097/QAI.0000000000001308.

31.

Spatial splay states and splay chimera states in coupled map lattices.

Singha J, Gupte N.

Phys Rev E. 2016 Nov;94(5-1):052204. Epub 2016 Nov 3.

PMID:
27967047
32.

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort.

Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Hakim J, Hosseinipour MC, Kumarasamy N, Sanne I, Asmuth D, Campbell T, Bollinger RC, Gupta A.

Open Forum Infect Dis. 2016 Jul 27;3(3):ofw118. eCollection 2016 Sep.

33.

Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.

Gupte N, Kinikar A, McIntire KN, Bhosale R, Patil S, Suryavanshi N, Mave V, Kulkarni V, Bollinger RC, Gupta A.

PLoS One. 2016 Sep 30;11(9):e0162979. doi: 10.1371/journal.pone.0162979. eCollection 2016.

34.

Synchronization in area-preserving maps: Effects of mixed phase space and coherent structures.

Mahata S, Das S, Gupte N.

Phys Rev E. 2016 Jun;93(6):062212. doi: 10.1103/PhysRevE.93.062212. Epub 2016 Jun 10.

PMID:
27415260
35.

Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation.

Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A; New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):123-9. doi: 10.1097/QAI.0000000000001095.

36.

Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.

Mave V, Chandanwale A, Kinikar A, Khadse S, Kagal A, Gupte N, Suryavanshi N, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Joshi S, Horng H, Benet LZ, Ramachandran G, Dooley KE, Gupta A, Gandhi M.

Int J Tuberc Lung Dis. 2016 Jun;20(6):844-7. doi: 10.5588/ijtld.15.0882.

37.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study Team.

J Infect Dis. 2016 Jul 1;214(1):65-72. doi: 10.1093/infdis/jiw096. Epub 2016 Mar 8.

38.

Bleomycin Containing Chemotherapeutic Regimen Induced Acquired Partial Lipodystrophy.

Tandon VR, Gupte N, Mahajan V, Sharma R, Langer C, Khajuria V, Mahajan A.

Indian J Dermatol. 2016 Jan-Feb;61(1):122. doi: 10.4103/0019-5154.174133.

39.

Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.

Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, Meshram S, Bharadwaj R, Khadse S, Ramachandran G, Hanna LE, Pradhan N, Gomathy NS, DeLuca A, Gupta A, Swaminathan S; CTRIUMPH Study Team.

BMJ Open. 2016 Feb 25;6(2):e010542. doi: 10.1136/bmjopen-2015-010542.

40.

Tuberculosis Risk among Medical Trainees, Pune, India.

Basavaraj A, Chandanwale A, Patil A, Kadam D, Joshi S, Gupte N, McIntire K, Jain D, Dalal H, Badave R, DeLuca A, Gupta A, Bollinger R, Mave V.

Emerg Infect Dis. 2016 Mar;22(3):541-3. doi: 10.3201/eid2203.151673.

41.

Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.

Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, Gupte N, Joshi S, Chandanwale A, Dupnik KM, Kulkarni V, Deshpande P, Fitzgerald DW, Gupta A.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1421-8. doi: 10.1164/rccm.201508-1595OC.

42.

Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.

Shivakoti R, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Balagopal A, Gupte N, Semba RD, Campbell TB, Bollinger RC, Gupta A; NWCS 319 and PEARLS Study Team.

J Infect Dis. 2016 Apr 1;213(7):1074-8. doi: 10.1093/infdis/jiv573. Epub 2015 Nov 29.

43.

Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis.

Shivakoti R, Gupta A, Ray JC, Uprety P, Gupte N, Bhosale R, Mave V, Patil S, Balasubramanian U, Kinikar A, Bharadwaj R, Bollinger RC, Persaud D.

J Infect Dis. 2016 Mar 1;213(5):762-5. doi: 10.1093/infdis/jiv479. Epub 2015 Oct 6.

44.

Hidden geometry of traffic jamming.

Andjelković M, Gupte N, Tadić B.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052817. Epub 2015 May 28.

PMID:
26066222
45.

Correction: CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort.

Martinson NA, Gupte N, Msandiwa R, Moulton LH, Barnes GL, Ram M, Gray G, Hoffmann C, Chaisson RE.

PLoS One. 2015 Jun 10;10(6):e0130509. doi: 10.1371/journal.pone.0130509. eCollection 2015. No abstract available.

46.

Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.

Dawson R, Narunsky K, Carman D, Gupte N, Whitelaw A, Efron A, Barnes GL, Hoffman J, Chaisson RE, McIlleron H, Dorman SE.

Int J Tuberc Lung Dis. 2015 Jul;19(7):780-6. doi: 10.5588/ijtld.14.0868.

PMID:
26056101
47.

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study team.

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):163-71. doi: 10.1097/QAI.0000000000000696.

48.

Sudarshan Kriya yoga improves quality of life in healthy people living with HIV (PLHIV): results from an open label randomized clinical trial.

Mawar N, Katendra T, Bagul R, Bembalkar S, Vedamurthachar A, Tripathy S, Srinivas K, Mandar K, Kumar N, Gupte N, Paranjape RS.

Indian J Med Res. 2015 Jan;141(1):90-9.

49.

Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.

Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A; New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Settings Study Team.

Clin Infect Dis. 2015 Jul 1;61(1):102-10. doi: 10.1093/cid/civ265. Epub 2015 Mar 31.

50.

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.

Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A; ACTG PEARLS and NWCS 319 Study Group.

PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. eCollection 2015.

Supplemental Content

Support Center